Catalyst
Slingshot members are tracking this event:
Eleven Bio (EBIO) Expects Topline Phase III Data for Vicinium in High Grade Non-Muscle Invasive Bladder Cancer in H1 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EBIO |
|
|
Viventia Bio |
|
|
SESN | Community voting in process |
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 21, 2018
Occurred Source:
http://ir.elevenbio.com/news-releases/news-release-details/phase-3-registration-trial-non-muscle-invasive-bladder-cancer
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Vicinium, High Grade Non-muscle Invasive Bladder Cancer, Topline Data, Phase Iii Results
